Allopurinol use during pediatric acute lymphoblastic leukemia maintenance therapy safely corrects skewed 6-mercaptopurine metabolism, improving inadequate myelosuppression and redu...

por Cohen, Gordon, Cooper, Stacy, Sison, Edward Allan, Annesley, Colleen, Bhuiyan, Mariam, Brown, Patrick
Publicado 2020

Plerixafor as a chemosensitizing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to CXCR4 inhibition

por Sison, Edward Allan R., Magoon, Daniel, Li, Li, Annesley, Colleen E., Rau, Rachel E., Small, Donald, Brown, Patrick
Publicado 2014

POL5551, a novel and potent CXCR4 antagonist, enhances sensitivity to chemotherapy in pediatric ALL

por Sison, Edward Allan R., Magoon, Daniel, Li, Li, Annesley, Colleen E., Romagnoli, Barbara, Douglas, Garry J., Tuffin, Gerald, Zimmermann, Johann, Brown, Patrick
Publicado 2015